- Home
- APVO vs PLRZ Comparison
APVO vs PLRZ Comparison
Compare APVO & PLRZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APVO
- PLRZ
- Stock Information
- Founded
- APVO 2016
- PLRZ 2005
- Country
- APVO United States
- PLRZ Israel
- Employees
- APVO N/A
- PLRZ N/A
- Industry
- APVO Biotechnology: Pharmaceutical Preparations
- PLRZ
- Sector
- APVO Health Care
- PLRZ
- Exchange
- APVO Nasdaq
- PLRZ NYSE
- Market Cap
- APVO 4.1M
- PLRZ 3.7M
- IPO Year
- APVO N/A
- PLRZ 2024
- Fundamental
- Price
- APVO $3.06
- PLRZ $1.54
- Analyst Decision
- APVO Strong Buy
- PLRZ
- Analyst Count
- APVO 1
- PLRZ 0
- Target Price
- APVO $5,920.00
- PLRZ N/A
- AVG Volume (30 Days)
- APVO 191.0K
- PLRZ 16.0M
- Earning Date
- APVO 08-07-2025
- PLRZ 02-15-2025
- Dividend Yield
- APVO N/A
- PLRZ N/A
- EPS Growth
- APVO N/A
- PLRZ N/A
- EPS
- APVO N/A
- PLRZ N/A
- Revenue
- APVO N/A
- PLRZ N/A
- Revenue This Year
- APVO N/A
- PLRZ N/A
- Revenue Next Year
- APVO N/A
- PLRZ N/A
- P/E Ratio
- APVO N/A
- PLRZ N/A
- Revenue Growth
- APVO N/A
- PLRZ N/A
- 52 Week Low
- APVO $2.81
- PLRZ $0.55
- 52 Week High
- APVO $381.10
- PLRZ $1,200.00
- Technical
- Relative Strength Index (RSI)
- APVO 38.28
- PLRZ N/A
- Support Level
- APVO $3.01
- PLRZ N/A
- Resistance Level
- APVO $3.18
- PLRZ N/A
- Average True Range (ATR)
- APVO 0.16
- PLRZ 0.00
- MACD
- APVO 0.19
- PLRZ 0.00
- Stochastic Oscillator
- APVO 45.45
- PLRZ 0.00
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
About PLRZ POLYRIZON LTD
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.